|
|
||||
 | ||||
|
|
Select from the search options to widen or narrow the search results.
Colon or Rectum Cancer ( CALGB/SWOG C80405) A Phase III Trial Of Irinotecan/5-FU/Leucovorin or Oxaliplatin/5-FU/Leucovorin with Bevacizumab, or Cetuximab (C225), or with the Combination of Bevacizumab and Cetuximab for Patients with Untreated Metastatic Adenocarcinoma of the Colon or Rectum; (C 80405)
Contact: For more information in Greenbay VLCC please coantct Lori McElrone 920-288-4174 lori.mcelrone@aurora.org or Kate Newbanks 920-288-4115 kate.newbanks@aurora.org For more information in Elkorn please contact Carol Thomas 414-649-5605 carol.thomas@aurora.org For more information in Slinger please contact Pamela Rynes 414-649-6067 pa.rynes@aurora.org For more information at Auroa St. Lukes Medical Consultants please contact Pamela Rynes 414-649-6067 pa.rynes@aurora.org For more information in Sheboygan VLCC please contact Mary Theodoroff 920-457-6800 ext. 2654 mary.theodoroff@aurora.org or Deborah Gray 920-457-6800 ext. 2660 deb.gray@aurora.org For more information in Oshkosh VLCC please contact Barb Esselman 920-456-7880 920-456-7870 barb.esselman@aurora.org For mor information in Two Rivers VLCC please contact Mary Jo Lindermann maryjo.lindermann@aurora. org
Clinical trial location(s)AMG - ABMC (incl. VLCC)2845 Greenbrier Road Green Bay, WI 54308-8900 Aurora St. Luke's Medical Center VLCC Sheboygan (AMG) VLCC - Elkhorn VLCC - Slinger VLCC- Oshkosh VLCC- Two Rivers
[ previous page ]
|
||
 |
||||
 |
 |
 |
|
 |
